Topical Itraconazole in Treating Patients With Basal Cell Cancer

Trial ID or NCT#

NCT02735356

Status

not recruiting iconNOT RECRUITING

Purpose

This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.

Official Title

A Case Study of the Effects of Topical Itraconazole on Pharmacodynamic Modulation of Hedgehog Target Gene Expression in Basal Cell Carcinomas in Patients

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Anthony Oro, MD, PhD
Anthony Oro, MD, PhD
Dermatologist, Hair loss specialist, Dermatologic oncologist, Cutaneous oncology specialist, Skin stem cell specialist
Eugene and Gloria Bauer Professor
Jean Y Tang
Jean Y Tang
General dermatologist, Dermatologic oncologist, Dermatologist, Cutaneous oncology specialist
Professor of Dermatology

Contact us to find out if this trial is right for you.

Contact

CCTO
650-498-7061